Termination Criteria Sample Clauses
POPULAR SAMPLE Copied 1 times
Termination Criteria. All ongoing enrolled patients will continue to be dosed until patient withdrawal, or the Investigator withdraws the patient from the Study.
Termination Criteria. The participant understands he/she may be terminated from the RCDC Program if he/she meet any of the following criteria:
Termination Criteria. 7. As noted in the service offer, a detailed timeline will be agreed upon during sprint 1 (project planning, specification, and environment setup). Both the Client and the Agency agree to commit to this timeline. The Client acknowledges that delays in communication or provision of information may result in delays to the project and accepts the responsibility of such delays.
8. The Agency undertakes to carry out the mandate within production deadlines as long as the Client cooperates and respects his commitments throughout the process. In order to speed up this validation process, the Agency strongly recommends that the Client assign a resource to the validation and providing of the content.
9. If the Client cannot fulfill its commitments to this mandate, the Agency’s ability to meet his own commitments and meet the “Termination criteria” could be compromised. In such case, the Client agrees to assume full responsibility for delays in the mandate, and accepts the additional costs incurred by the loss of time caused, to offset the commitments and responsibilities of the Agent.
Termination Criteria. Termination from the ALERT Program is possible. You will be classified as an unsuccessful termination if you are found to be in non-compliance with the terms and conditions of the ALERT Program. Typically, an unsuccessful termination is a result of being found guilty of a community control violation and the revocation of community control. The criteria for termination from the ALERT Program is set forth in the ALERT Program Description.
Termination Criteria. Enrollment in the study will end when at least 175 subjects have been enrolled, to provide approximately 88 subjects per treatment group. Subjects who discontinue the study prior to receiving their first dose of IP will be replaced. A dropout rate of approximately 10% over the life of the study is assumed. The end of the trial is defined as the date when the final analysis of the OS endpoint is completed.
Termination Criteria